Trial Profile
Clinical Trials Insight: 700047784
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Aug 2009
Price :
$35
*
At a glance
- Drugs Bremelanotide (Primary)
- Indications Erectile dysfunction; Female sexual dysfunction
- Focus Adverse reactions
- Sponsors Palatin Technologies
- 13 Aug 2009 New trial record.